Insight

Liquid Biopsy Breakthrough – International Society of Liquid Biopsy

nature.com

Jan 15, 2025, 16:20

Liquid Biopsy Breakthrough – International Society of Liquid Biopsy

International Society of Liquid Biopsy (ISLB) shared a post on X about a recent paper by James Black et al. published in Nature Medicine:

“Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma”

Authors: James Black, Gabor Bartha, Charles Abbott, Richard Chen, Charles Swanton et al.

Liquid Biopsy Breakthrough - International Society of Liquid Biopsy

“Liquid Biopsy Breakthrough.

New ultrasensitive ctDNA detection tools like NeXT Personal achieve unparalleled sensitivity (1–3 ppm). This can revolutionize early-stage NSCLC management by:

Pre-op disease stratification
Predicting worse clinical outcomes
Identifying ultra-low-risk patients

Study Highlights:

81% detection in LUAD pre-op cases.
Significant OS impact: ctDNA presence = poorer survival.”

More posts International Society of Liquid Biopsy.

cancer Charles Abbott Charles Swanton ctDNA Gabor Bartha International Society of Liquid Biopsy ISLB James Black liquid biopsy lung adenocarcinoma OncoDaily Oncology Richard Chen

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage